Skip to main content
. 2017 Jun 26;7(6):e013431. doi: 10.1136/bmjopen-2016-013431

Table 4.

Discrimination of adverse outcomes with the addition of high-sensitivity cardiac troponin T (hs-cTnT) to the clinical risk factor model

Endpoint C-statistics (95% CI)
Clinical model Clinical model + hs-cTnT p Value
All-cause mortality 0.671 (0.646 to 0.704) 0.698 (0.680 to 0.725) 0.003
Major adverse cardiovascular event 0.702 (0.680 to 0.726) 0.734 (0.714 to 0.758) <0.001
Coronary event 0.713 (0.701 to 0.735) 0.749 (0.729 to 0.768) <0.001
Stroke event 0.683 (0.665 to 0.709) 0.697 (0.674 to 0.729) 0.09

The clinical risk factor model included age, gender, body mass index, current smoking status, diabetes mellitus, systolic blood pressure, diastolic blood pressure, total cholesterol, high-density lipoprotein cholesterol and estimated glomerular filtration rate.